Baidu
map
ANN PALLIAT MED 润色咨询

Annals of Palliative Medicine

出版年份：暂无数据 年文章数：425 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=911427, encodeId=beba91142edf, content=一个多月了，还在under view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Sun Dec 27 21:38:03 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214046, encodeId=f98212140464d, content=快，安全，需，可联系, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d04b8117489, createdName=ms7000000149540875, createdTime=Mon Apr 25 09:05:26 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120960, encodeId=75fe21209607f, content=审稿速度:2.0 | 投稿命中率:95.0<br>偏重的研究方向：姑息医学;肿瘤<br>经验分享：刚刚被踢出SCI期刊索引，大家要小心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Mar 22 07:23:53 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=802971, encodeId=fa428029e178, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：一审10天不到，直接回大修，填一个checklist。降低重复率，效率真的高！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/15/1803653964003c06525a0b4c44104bd7.jpg, createdBy=ba342431868, createdName=123ba159m28暂无昵称, createdTime=Thu Jul 16 10:35:44 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096368, encodeId=c37f2096368e5, content=一直Under review 现在从step1刚跳到step3 什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44725437050, createdName=ms2000000766234501, createdTime=Thu Oct 27 00:32:15 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103315, encodeId=fabc21033150b, content=偏重的研究方向：肿瘤<br>经验分享：11.25投稿，还在awaiting assignment。。。还不知道后续如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IkpibcjZM6dwuaic9HxhAS60oibibEnQNSh51UANKBptVhHht5D8qY6HSKyHGqib2XqD9695walIibHpC0e5PdicOYic9A/132, createdBy=e9b42414696, createdName=Layee, createdTime=Tue Nov 29 14:56:26 CST 2022, time=2022-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1231701, encodeId=f3b21231e0123, content=请问细胞试验用什么reporting checklis呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=166b1854417, createdName=ms3223109900227850, createdTime=Sun Jul 10 23:03:38 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230861, encodeId=3d4212308612b, content=2022影响因子1.925, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Wed Jul 06 10:15:16 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084171, encodeId=f27f10841e117, content=有无最近刚投的，想问下meta分析现在还收吗？初审大概多久？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7c75421892, createdName=ms5000001780828736, createdTime=Sat Dec 25 16:08:09 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006836, encodeId=5acb1006836da, content=请问apm接收骨科 临床类型文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58f65569032, createdName=ms2000000640264829, createdTime=Wed Aug 11 07:48:06 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2020-12-27 lancet1111

    一个多月了，还在under view

    11

    展开11条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=911427, encodeId=beba91142edf, content=一个多月了，还在under view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Sun Dec 27 21:38:03 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214046, encodeId=f98212140464d, content=快，安全，需，可联系, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d04b8117489, createdName=ms7000000149540875, createdTime=Mon Apr 25 09:05:26 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120960, encodeId=75fe21209607f, content=审稿速度:2.0 | 投稿命中率:95.0<br>偏重的研究方向：姑息医学;肿瘤<br>经验分享：刚刚被踢出SCI期刊索引，大家要小心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Mar 22 07:23:53 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=802971, encodeId=fa428029e178, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：一审10天不到，直接回大修，填一个checklist。降低重复率，效率真的高！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/15/1803653964003c06525a0b4c44104bd7.jpg, createdBy=ba342431868, createdName=123ba159m28暂无昵称, createdTime=Thu Jul 16 10:35:44 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096368, encodeId=c37f2096368e5, content=一直Under review 现在从step1刚跳到step3 什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44725437050, createdName=ms2000000766234501, createdTime=Thu Oct 27 00:32:15 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103315, encodeId=fabc21033150b, content=偏重的研究方向：肿瘤<br>经验分享：11.25投稿，还在awaiting assignment。。。还不知道后续如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IkpibcjZM6dwuaic9HxhAS60oibibEnQNSh51UANKBptVhHht5D8qY6HSKyHGqib2XqD9695walIibHpC0e5PdicOYic9A/132, createdBy=e9b42414696, createdName=Layee, createdTime=Tue Nov 29 14:56:26 CST 2022, time=2022-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1231701, encodeId=f3b21231e0123, content=请问细胞试验用什么reporting checklis呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=166b1854417, createdName=ms3223109900227850, createdTime=Sun Jul 10 23:03:38 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230861, encodeId=3d4212308612b, content=2022影响因子1.925, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Wed Jul 06 10:15:16 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084171, encodeId=f27f10841e117, content=有无最近刚投的，想问下meta分析现在还收吗？初审大概多久？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7c75421892, createdName=ms5000001780828736, createdTime=Sat Dec 25 16:08:09 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006836, encodeId=5acb1006836da, content=请问apm接收骨科 临床类型文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58f65569032, createdName=ms2000000640264829, createdTime=Wed Aug 11 07:48:06 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2022-04-25 ms7000000149540875

    快，安全，需，可联系

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=911427, encodeId=beba91142edf, content=一个多月了，还在under view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Sun Dec 27 21:38:03 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214046, encodeId=f98212140464d, content=快，安全，需，可联系, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d04b8117489, createdName=ms7000000149540875, createdTime=Mon Apr 25 09:05:26 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120960, encodeId=75fe21209607f, content=审稿速度:2.0 | 投稿命中率:95.0<br>偏重的研究方向：姑息医学;肿瘤<br>经验分享：刚刚被踢出SCI期刊索引，大家要小心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Mar 22 07:23:53 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=802971, encodeId=fa428029e178, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：一审10天不到，直接回大修，填一个checklist。降低重复率，效率真的高！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/15/1803653964003c06525a0b4c44104bd7.jpg, createdBy=ba342431868, createdName=123ba159m28暂无昵称, createdTime=Thu Jul 16 10:35:44 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096368, encodeId=c37f2096368e5, content=一直Under review 现在从step1刚跳到step3 什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44725437050, createdName=ms2000000766234501, createdTime=Thu Oct 27 00:32:15 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103315, encodeId=fabc21033150b, content=偏重的研究方向：肿瘤<br>经验分享：11.25投稿，还在awaiting assignment。。。还不知道后续如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IkpibcjZM6dwuaic9HxhAS60oibibEnQNSh51UANKBptVhHht5D8qY6HSKyHGqib2XqD9695walIibHpC0e5PdicOYic9A/132, createdBy=e9b42414696, createdName=Layee, createdTime=Tue Nov 29 14:56:26 CST 2022, time=2022-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1231701, encodeId=f3b21231e0123, content=请问细胞试验用什么reporting checklis呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=166b1854417, createdName=ms3223109900227850, createdTime=Sun Jul 10 23:03:38 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230861, encodeId=3d4212308612b, content=2022影响因子1.925, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Wed Jul 06 10:15:16 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084171, encodeId=f27f10841e117, content=有无最近刚投的，想问下meta分析现在还收吗？初审大概多久？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7c75421892, createdName=ms5000001780828736, createdTime=Sat Dec 25 16:08:09 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006836, encodeId=5acb1006836da, content=请问apm接收骨科 临床类型文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58f65569032, createdName=ms2000000640264829, createdTime=Wed Aug 11 07:48:06 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2023-03-22 侠胆医心 来自上海

    审稿速度:2.0 | 投稿命中率:95.0
    偏重的研究方向：姑息医学;肿瘤
    经验分享：刚刚被踢出SCI期刊索引，大家要小心了

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=911427, encodeId=beba91142edf, content=一个多月了，还在under view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Sun Dec 27 21:38:03 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214046, encodeId=f98212140464d, content=快，安全，需，可联系, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d04b8117489, createdName=ms7000000149540875, createdTime=Mon Apr 25 09:05:26 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120960, encodeId=75fe21209607f, content=审稿速度:2.0 | 投稿命中率:95.0<br>偏重的研究方向：姑息医学;肿瘤<br>经验分享：刚刚被踢出SCI期刊索引，大家要小心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Mar 22 07:23:53 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=802971, encodeId=fa428029e178, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：一审10天不到，直接回大修，填一个checklist。降低重复率，效率真的高！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/15/1803653964003c06525a0b4c44104bd7.jpg, createdBy=ba342431868, createdName=123ba159m28暂无昵称, createdTime=Thu Jul 16 10:35:44 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096368, encodeId=c37f2096368e5, content=一直Under review 现在从step1刚跳到step3 什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44725437050, createdName=ms2000000766234501, createdTime=Thu Oct 27 00:32:15 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103315, encodeId=fabc21033150b, content=偏重的研究方向：肿瘤<br>经验分享：11.25投稿，还在awaiting assignment。。。还不知道后续如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IkpibcjZM6dwuaic9HxhAS60oibibEnQNSh51UANKBptVhHht5D8qY6HSKyHGqib2XqD9695walIibHpC0e5PdicOYic9A/132, createdBy=e9b42414696, createdName=Layee, createdTime=Tue Nov 29 14:56:26 CST 2022, time=2022-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1231701, encodeId=f3b21231e0123, content=请问细胞试验用什么reporting checklis呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=166b1854417, createdName=ms3223109900227850, createdTime=Sun Jul 10 23:03:38 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230861, encodeId=3d4212308612b, content=2022影响因子1.925, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Wed Jul 06 10:15:16 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084171, encodeId=f27f10841e117, content=有无最近刚投的，想问下meta分析现在还收吗？初审大概多久？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7c75421892, createdName=ms5000001780828736, createdTime=Sat Dec 25 16:08:09 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006836, encodeId=5acb1006836da, content=请问apm接收骨科 临床类型文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58f65569032, createdName=ms2000000640264829, createdTime=Wed Aug 11 07:48:06 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2020-07-16 123ba159m28暂无昵称

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享：一审10天不到，直接回大修，填一个checklist。降低重复率，效率真的高！！！

    4

    展开4条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=911427, encodeId=beba91142edf, content=一个多月了，还在under view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Sun Dec 27 21:38:03 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214046, encodeId=f98212140464d, content=快，安全，需，可联系, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d04b8117489, createdName=ms7000000149540875, createdTime=Mon Apr 25 09:05:26 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120960, encodeId=75fe21209607f, content=审稿速度:2.0 | 投稿命中率:95.0<br>偏重的研究方向：姑息医学;肿瘤<br>经验分享：刚刚被踢出SCI期刊索引，大家要小心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Mar 22 07:23:53 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=802971, encodeId=fa428029e178, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：一审10天不到，直接回大修，填一个checklist。降低重复率，效率真的高！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/15/1803653964003c06525a0b4c44104bd7.jpg, createdBy=ba342431868, createdName=123ba159m28暂无昵称, createdTime=Thu Jul 16 10:35:44 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096368, encodeId=c37f2096368e5, content=一直Under review 现在从step1刚跳到step3 什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44725437050, createdName=ms2000000766234501, createdTime=Thu Oct 27 00:32:15 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103315, encodeId=fabc21033150b, content=偏重的研究方向：肿瘤<br>经验分享：11.25投稿，还在awaiting assignment。。。还不知道后续如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IkpibcjZM6dwuaic9HxhAS60oibibEnQNSh51UANKBptVhHht5D8qY6HSKyHGqib2XqD9695walIibHpC0e5PdicOYic9A/132, createdBy=e9b42414696, createdName=Layee, createdTime=Tue Nov 29 14:56:26 CST 2022, time=2022-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1231701, encodeId=f3b21231e0123, content=请问细胞试验用什么reporting checklis呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=166b1854417, createdName=ms3223109900227850, createdTime=Sun Jul 10 23:03:38 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230861, encodeId=3d4212308612b, content=2022影响因子1.925, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Wed Jul 06 10:15:16 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084171, encodeId=f27f10841e117, content=有无最近刚投的，想问下meta分析现在还收吗？初审大概多久？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7c75421892, createdName=ms5000001780828736, createdTime=Sat Dec 25 16:08:09 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006836, encodeId=5acb1006836da, content=请问apm接收骨科 临床类型文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58f65569032, createdName=ms2000000640264829, createdTime=Wed Aug 11 07:48:06 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2022-10-27 ms2000000766234501

    一直Under review 现在从step1刚跳到step3 什么意思？

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=911427, encodeId=beba91142edf, content=一个多月了，还在under view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Sun Dec 27 21:38:03 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214046, encodeId=f98212140464d, content=快，安全，需，可联系, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d04b8117489, createdName=ms7000000149540875, createdTime=Mon Apr 25 09:05:26 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120960, encodeId=75fe21209607f, content=审稿速度:2.0 | 投稿命中率:95.0<br>偏重的研究方向：姑息医学;肿瘤<br>经验分享：刚刚被踢出SCI期刊索引，大家要小心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Mar 22 07:23:53 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=802971, encodeId=fa428029e178, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：一审10天不到，直接回大修，填一个checklist。降低重复率，效率真的高！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/15/1803653964003c06525a0b4c44104bd7.jpg, createdBy=ba342431868, createdName=123ba159m28暂无昵称, createdTime=Thu Jul 16 10:35:44 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096368, encodeId=c37f2096368e5, content=一直Under review 现在从step1刚跳到step3 什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44725437050, createdName=ms2000000766234501, createdTime=Thu Oct 27 00:32:15 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103315, encodeId=fabc21033150b, content=偏重的研究方向：肿瘤<br>经验分享：11.25投稿，还在awaiting assignment。。。还不知道后续如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IkpibcjZM6dwuaic9HxhAS60oibibEnQNSh51UANKBptVhHht5D8qY6HSKyHGqib2XqD9695walIibHpC0e5PdicOYic9A/132, createdBy=e9b42414696, createdName=Layee, createdTime=Tue Nov 29 14:56:26 CST 2022, time=2022-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1231701, encodeId=f3b21231e0123, content=请问细胞试验用什么reporting checklis呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=166b1854417, createdName=ms3223109900227850, createdTime=Sun Jul 10 23:03:38 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230861, encodeId=3d4212308612b, content=2022影响因子1.925, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Wed Jul 06 10:15:16 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084171, encodeId=f27f10841e117, content=有无最近刚投的，想问下meta分析现在还收吗？初审大概多久？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7c75421892, createdName=ms5000001780828736, createdTime=Sat Dec 25 16:08:09 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006836, encodeId=5acb1006836da, content=请问apm接收骨科 临床类型文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58f65569032, createdName=ms2000000640264829, createdTime=Wed Aug 11 07:48:06 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2022-11-29 Layee 来自江苏省

    偏重的研究方向：肿瘤
    经验分享：11.25投稿，还在awaiting assignment。。。还不知道后续如何

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=911427, encodeId=beba91142edf, content=一个多月了，还在under view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Sun Dec 27 21:38:03 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214046, encodeId=f98212140464d, content=快，安全，需，可联系, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d04b8117489, createdName=ms7000000149540875, createdTime=Mon Apr 25 09:05:26 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120960, encodeId=75fe21209607f, content=审稿速度:2.0 | 投稿命中率:95.0<br>偏重的研究方向：姑息医学;肿瘤<br>经验分享：刚刚被踢出SCI期刊索引，大家要小心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Mar 22 07:23:53 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=802971, encodeId=fa428029e178, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：一审10天不到，直接回大修，填一个checklist。降低重复率，效率真的高！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/15/1803653964003c06525a0b4c44104bd7.jpg, createdBy=ba342431868, createdName=123ba159m28暂无昵称, createdTime=Thu Jul 16 10:35:44 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096368, encodeId=c37f2096368e5, content=一直Under review 现在从step1刚跳到step3 什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44725437050, createdName=ms2000000766234501, createdTime=Thu Oct 27 00:32:15 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103315, encodeId=fabc21033150b, content=偏重的研究方向：肿瘤<br>经验分享：11.25投稿，还在awaiting assignment。。。还不知道后续如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IkpibcjZM6dwuaic9HxhAS60oibibEnQNSh51UANKBptVhHht5D8qY6HSKyHGqib2XqD9695walIibHpC0e5PdicOYic9A/132, createdBy=e9b42414696, createdName=Layee, createdTime=Tue Nov 29 14:56:26 CST 2022, time=2022-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1231701, encodeId=f3b21231e0123, content=请问细胞试验用什么reporting checklis呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=166b1854417, createdName=ms3223109900227850, createdTime=Sun Jul 10 23:03:38 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230861, encodeId=3d4212308612b, content=2022影响因子1.925, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Wed Jul 06 10:15:16 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084171, encodeId=f27f10841e117, content=有无最近刚投的，想问下meta分析现在还收吗？初审大概多久？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7c75421892, createdName=ms5000001780828736, createdTime=Sat Dec 25 16:08:09 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006836, encodeId=5acb1006836da, content=请问apm接收骨科 临床类型文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58f65569032, createdName=ms2000000640264829, createdTime=Wed Aug 11 07:48:06 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2022-07-10 ms3223109900227850

    请问细胞试验用什么reporting checklis呢

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=911427, encodeId=beba91142edf, content=一个多月了，还在under view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Sun Dec 27 21:38:03 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214046, encodeId=f98212140464d, content=快，安全，需，可联系, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d04b8117489, createdName=ms7000000149540875, createdTime=Mon Apr 25 09:05:26 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120960, encodeId=75fe21209607f, content=审稿速度:2.0 | 投稿命中率:95.0<br>偏重的研究方向：姑息医学;肿瘤<br>经验分享：刚刚被踢出SCI期刊索引，大家要小心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Mar 22 07:23:53 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=802971, encodeId=fa428029e178, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：一审10天不到，直接回大修，填一个checklist。降低重复率，效率真的高！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/15/1803653964003c06525a0b4c44104bd7.jpg, createdBy=ba342431868, createdName=123ba159m28暂无昵称, createdTime=Thu Jul 16 10:35:44 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096368, encodeId=c37f2096368e5, content=一直Under review 现在从step1刚跳到step3 什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44725437050, createdName=ms2000000766234501, createdTime=Thu Oct 27 00:32:15 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103315, encodeId=fabc21033150b, content=偏重的研究方向：肿瘤<br>经验分享：11.25投稿，还在awaiting assignment。。。还不知道后续如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IkpibcjZM6dwuaic9HxhAS60oibibEnQNSh51UANKBptVhHht5D8qY6HSKyHGqib2XqD9695walIibHpC0e5PdicOYic9A/132, createdBy=e9b42414696, createdName=Layee, createdTime=Tue Nov 29 14:56:26 CST 2022, time=2022-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1231701, encodeId=f3b21231e0123, content=请问细胞试验用什么reporting checklis呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=166b1854417, createdName=ms3223109900227850, createdTime=Sun Jul 10 23:03:38 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230861, encodeId=3d4212308612b, content=2022影响因子1.925, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Wed Jul 06 10:15:16 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084171, encodeId=f27f10841e117, content=有无最近刚投的，想问下meta分析现在还收吗？初审大概多久？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7c75421892, createdName=ms5000001780828736, createdTime=Sat Dec 25 16:08:09 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006836, encodeId=5acb1006836da, content=请问apm接收骨科 临床类型文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58f65569032, createdName=ms2000000640264829, createdTime=Wed Aug 11 07:48:06 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2022-07-06 ms7000002110969436

    2022影响因子1.925

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=911427, encodeId=beba91142edf, content=一个多月了，还在under view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Sun Dec 27 21:38:03 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214046, encodeId=f98212140464d, content=快，安全，需，可联系, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d04b8117489, createdName=ms7000000149540875, createdTime=Mon Apr 25 09:05:26 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120960, encodeId=75fe21209607f, content=审稿速度:2.0 | 投稿命中率:95.0<br>偏重的研究方向：姑息医学;肿瘤<br>经验分享：刚刚被踢出SCI期刊索引，大家要小心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Mar 22 07:23:53 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=802971, encodeId=fa428029e178, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：一审10天不到，直接回大修，填一个checklist。降低重复率，效率真的高！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/15/1803653964003c06525a0b4c44104bd7.jpg, createdBy=ba342431868, createdName=123ba159m28暂无昵称, createdTime=Thu Jul 16 10:35:44 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096368, encodeId=c37f2096368e5, content=一直Under review 现在从step1刚跳到step3 什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44725437050, createdName=ms2000000766234501, createdTime=Thu Oct 27 00:32:15 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103315, encodeId=fabc21033150b, content=偏重的研究方向：肿瘤<br>经验分享：11.25投稿，还在awaiting assignment。。。还不知道后续如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IkpibcjZM6dwuaic9HxhAS60oibibEnQNSh51UANKBptVhHht5D8qY6HSKyHGqib2XqD9695walIibHpC0e5PdicOYic9A/132, createdBy=e9b42414696, createdName=Layee, createdTime=Tue Nov 29 14:56:26 CST 2022, time=2022-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1231701, encodeId=f3b21231e0123, content=请问细胞试验用什么reporting checklis呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=166b1854417, createdName=ms3223109900227850, createdTime=Sun Jul 10 23:03:38 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230861, encodeId=3d4212308612b, content=2022影响因子1.925, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Wed Jul 06 10:15:16 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084171, encodeId=f27f10841e117, content=有无最近刚投的，想问下meta分析现在还收吗？初审大概多久？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7c75421892, createdName=ms5000001780828736, createdTime=Sat Dec 25 16:08:09 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006836, encodeId=5acb1006836da, content=请问apm接收骨科 临床类型文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58f65569032, createdName=ms2000000640264829, createdTime=Wed Aug 11 07:48:06 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2021-12-25 ms5000001780828736

    有无最近刚投的，想问下meta分析现在还收吗？初审大概多久？

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=911427, encodeId=beba91142edf, content=一个多月了，还在under view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Sun Dec 27 21:38:03 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214046, encodeId=f98212140464d, content=快，安全，需，可联系, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d04b8117489, createdName=ms7000000149540875, createdTime=Mon Apr 25 09:05:26 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120960, encodeId=75fe21209607f, content=审稿速度:2.0 | 投稿命中率:95.0<br>偏重的研究方向：姑息医学;肿瘤<br>经验分享：刚刚被踢出SCI期刊索引，大家要小心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Mar 22 07:23:53 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=802971, encodeId=fa428029e178, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：一审10天不到，直接回大修，填一个checklist。降低重复率，效率真的高！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/15/1803653964003c06525a0b4c44104bd7.jpg, createdBy=ba342431868, createdName=123ba159m28暂无昵称, createdTime=Thu Jul 16 10:35:44 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096368, encodeId=c37f2096368e5, content=一直Under review 现在从step1刚跳到step3 什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44725437050, createdName=ms2000000766234501, createdTime=Thu Oct 27 00:32:15 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103315, encodeId=fabc21033150b, content=偏重的研究方向：肿瘤<br>经验分享：11.25投稿，还在awaiting assignment。。。还不知道后续如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IkpibcjZM6dwuaic9HxhAS60oibibEnQNSh51UANKBptVhHht5D8qY6HSKyHGqib2XqD9695walIibHpC0e5PdicOYic9A/132, createdBy=e9b42414696, createdName=Layee, createdTime=Tue Nov 29 14:56:26 CST 2022, time=2022-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1231701, encodeId=f3b21231e0123, content=请问细胞试验用什么reporting checklis呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=166b1854417, createdName=ms3223109900227850, createdTime=Sun Jul 10 23:03:38 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230861, encodeId=3d4212308612b, content=2022影响因子1.925, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Wed Jul 06 10:15:16 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084171, encodeId=f27f10841e117, content=有无最近刚投的，想问下meta分析现在还收吗？初审大概多久？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7c75421892, createdName=ms5000001780828736, createdTime=Sat Dec 25 16:08:09 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006836, encodeId=5acb1006836da, content=请问apm接收骨科 临床类型文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58f65569032, createdName=ms2000000640264829, createdTime=Wed Aug 11 07:48:06 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2021-08-11 ms2000000640264829

    请问apm接收骨科 临床类型文章么

    2

    展开2条回复
共194条页码: 1/20页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map